Bliss DTx Assessment During Course Care Including Port-A-Catheter Setting

Launched by BUTTERFLY THERAPEUTICS · Jul 2, 2024

Keywords

ClinConnect Summary

The Bliss DTx trial is studying a new way to help manage pain and anxiety for cancer patients undergoing a procedure called Port-a-Cath placement. This procedure involves placing a small device under the skin to make it easier to receive treatments like chemotherapy. The trial is testing a virtual reality program called Bliss DTx, which aims to provide comfort and distraction during the procedure, comparing it to standard sedation methods like medication. Researchers want to see if Bliss DTx can help patients feel less anxious and more satisfied with their experience.

To be eligible for this trial, participants must be adults aged 18 or older with a cancer diagnosis who need a Port-a-Cath placed. They should be able to understand French and must give their consent to participate. Unfortunately, those who have had this procedure before, have certain pain conditions, or are pregnant cannot join. Participants in the trial can expect to engage with the virtual reality program during their procedure and contribute to research that could improve the treatment experience for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient, male or female, aged ≥ 18 years
• • Patient with a cancer diagnosis
• • Patient with Port-A-Cath setting under ambulatory
• • Patient affiliated to or beneficiary of a social security system
• • French speaking patient having signed informed consent
• Exclusion Criteria:
• • Patient with previous Port-A-Cath setting
• • Patient with pain perception disorder
• • Patient with contraindication to the use of virtual reality (VR) and screens
• • Pregnant woman
• • Protected patient